QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
QQQ   319.26 (-1.34%)
AAPL   125.22 (-2.01%)
MSFT   234.58 (-1.00%)
FB   260.45 (-1.68%)
GOOGL   2,067.00 (-0.13%)
TSLA   686.37 (-4.46%)
AMZN   3,093.51 (-1.67%)
NVDA   539.35 (-2.59%)
BABA   235.11 (-2.72%)
CGC   35.01 (+0.81%)
GE   13.02 (-0.69%)
MU   91.64 (-3.29%)
NIO   43.20 (-13.18%)
AMD   84.71 (-1.94%)
T   28.36 (+0.96%)
F   12.63 (+5.43%)
ACB   11.06 (+0.18%)
DIS   193.86 (-0.57%)
BA   223.93 (-0.21%)
NFLX   548.09 (-0.46%)
BAC   35.67 (-0.34%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Bio-TechneCRISPR TherapeuticsargenxQIAGENRepligen
SymbolNASDAQ:TECHNASDAQ:CRSPNASDAQ:ARGXNYSE:QGENNASDAQ:RGEN
Price Information
Current Price$376.00$130.15$335.18$50.43$212.69
52 Week RangeBuyBuyBuyBuyBuy
MarketRank™
Overall Score1.81.51.11.71.5
Analysis Score1.33.32.33.31.5
Community Score2.32.72.52.32.6
Dividend Score1.70.00.00.00.0
Ownership Score1.71.70.80.81.7
Earnings & Valuation Score1.90.00.01.91.9
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$352.30$150.20$286.82$56.37$204.75
% Upside from Price Target-6.30% downside15.41% upside-14.43% downside11.78% upside-3.73% downside
Trade Information
Market Cap$14.45 billion$9.82 billion$16.12 billion$11.47 billion$12.14 billion
Beta1.132.3710.410.94
Average Volume195,6922,486,028213,291965,467379,766
Sales & Book Value
Annual Revenue$738.69 million$289.59 million$78.17 million$1.53 billion$270.24 million
Price / Sales19.7533.90202.997.5243.11
Cashflow$6.99 per share$0.84 per shareN/A$2.51 per share$1.44 per share
Price / Cash53.77154.11N/A20.07147.51
Book Value$36.13 per share$17.02 per share$30.88 per share$11.14 per share$20.36 per share
Price / Book10.417.6510.854.5310.45
Profitability
Net Income$229.30 million$66.86 million$-182,520,000.00$-41,460,000.00$21.41 million
EPS$3.86$1.17($4.73)$1.43$1.07
Trailing P/E Ratio60.16N/AN/A62.26259.38
Forward P/E Ratio64.27N/AN/A20.58128.13
P/E Growth7.23N/AN/A1.294.18
Net Margins32.69%-273.10%N/A11.18%13.40%
Return on Equity (ROE)12.20%-20.72%N/A17.51%6.58%
Return on Assets (ROA)8.09%-18.35%N/A8.44%5.00%
Dividend
Annual Payout$1.28N/AN/AN/AN/A
Dividend Yield0.34%N/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout Ratio33.16%N/AN/AN/AN/A
Years of Consecutive Dividend Growth1 YearsN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.22%N/AN/A0.52%0.21%
Current Ratio5.14%16.53%9.90%1.46%13.67%
Quick Ratio4.13%16.53%9.87%1.22%12.13%
Ownership Information
Institutional Ownership Percentage93.75%66.43%54.21%43.64%84.33%
Insider Ownership Percentage3.80%17.10%N/A9.00%1.70%
Miscellaneous
Employees2,3003041865,300761
Shares Outstanding38.80 million75.43 million47.34 million227.75 million54.77 million
Next Earnings Date4/29/2021 (Estimated)4/27/2021 (Estimated)3/4/2021 (Confirmed)5/5/2021 (Estimated)5/5/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.